Loracarbef Articles
King Pharmaceuticals 2nd-qtr earnings leap 77%
25 July 2001
Eli Lilly signs glucagon deal with E-Z-EM
24 August 1999
King acquires certain rights to Lilly's Lorabid
5 August 1999
US Quarterly Financial Results Round-Up
23 April 1998
Lilly Signs $100 Million Antibiotic Deal With Dura
2 September 1996
Mixed Earnings But Strong Sales For US Companies
12 February 1996
Eli Lilly Opens Manufacturing Plant
6 March 1995
RECALL HITS 1st-QTR NET PROFITS AT LILLY
25 April 1994
LILLY RECALLS ANTIBIOTICS
11 April 1994
RESTRUCTURING CHARGES DEPRESS LILLY AND E KODAK
14 February 1994
ELI LILLY'S GERMAN SALES DECLINE
15 November 1993
NEW CHEMICAL ENTITIES LAUNCHED IN 1992
1 February 1993
JOB CUTS AT BRISTOL-MYERS SQUIBB
9 November 1992
BIOCRAFT SETS SIGHTS ON GENERIC CECLOR
17 February 1992
NEW CHEMICAL ENTITIES UPDATE FOR 1991
10 February 1992
DECEMBER US APPROS REVIEWED
20 January 1992
KYOWA HAKKO TO EXPAND OVERSEAS
13 January 1992
US FDA BEATS 1990 DRUG APPROVALS IN 1991
13 January 1992
Showing 1-18 of 18 articles
- 1
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
